NLS Pharma Business

Pharma Business - June 11, 2026

Camurus receives FDA setback for CAM2029 in US acromegaly review

Camurus has received a Complete Response Letter from the US Food and Drug Administration regarding its New Drug Application for CAM2029 (Oclaiz), a once-monthly octreotide treatment for patients with acromegaly.

In a new job - June 9, 2026

Orexo strengthens its business development efforts

The company is strengthening its focus on new partnerships through the appointment of Raheleh Nassaji as Senior Vice President Business Development.

Agreement - June 9, 2026

AlzeCure Pharma enters collaboration and out-licensing agreement with Lilly

AlzeCure Pharma has entered into a collaboration and out-licensing agreement with the pharmaceutical company Eli Lilly and Company regarding the global rights to the Alzheimer’s project Alzstatin ACD680.

Collaboration - June 8, 2026

Moberg Pharma and Karo Healthcare expand collaboration for MOB-015/Terclara to China

Moberg Pharma has entered into a license agreement with Karo Healthcare regarding the commercialization of the nail fungus drug MOB-015 (Terclara) in China through the rapidly growing cross-border e-commerce channel.

Clinical Trials - June 8, 2026

Pharmability submits clinical trial application for first-in-human Phase Ib study 

Pharmability has announced the submission of a Clinical Trial Application (CTA) for TIR-C, the company's lead drug candidate for atopic dermatitis (eczema).

Pharma Business - June 5, 2026

Diamyd Medical provides business update

As part of an ongoing strategic review, the company has received several proposals from external parties, including formal non-binding Letters of Intent, as well as invitations to invest into various business opportunities, it states.

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.